Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Onsemi stock logo
ON
Onsemi
$42.15
-1.6%
$52.01
$41.59
$80.08
$17.76B1.596.78 million shs6.25 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.60
-0.4%
$26.26
$24.48
$31.54
$145.08B0.6140.06 million shs36.67 million shs
RH stock logo
RH
RH
$216.62
-10.1%
$375.24
$212.04
$457.26
$4.03B2.5750,183 shs1.42 million shs
Roche Holding AG stock logo
RHHBY
Roche
$42.86
-1.6%
$39.65
$29.20
$43.96
$273.36B0.412.95 million shs1.99 million shs
Roche Holding AG stock logo
RHHVF
Roche
$341.79
-1.5%
$316.13
$233.12
$351.40
N/AN/A4,580 shs1,537 shs
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$98.37
-1.4%
$112.83
$97.11
$173.25
$9.55B0.79917,879 shs736,577 shs
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$10.27
-5.0%
$11.25
$4.25
$16.74
$1.58B-1.041.10 million shs1.08 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Onsemi stock logo
ON
Onsemi
-1.63%-3.94%-12.06%-36.10%-47.24%
Pfizer Inc. stock logo
PFE
Pfizer
-0.49%-2.31%+0.26%+0.07%-9.24%
RH stock logo
RH
RH
-10.10%-22.84%-43.73%-51.42%-28.57%
Roche Holding AG stock logo
RHHBY
Roche
-1.61%-0.44%+8.70%+21.11%+25.25%
Roche Holding AG stock logo
RHHVF
Roche
-1.50%-0.06%+8.16%+20.26%+25.52%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
-1.40%-6.81%-10.31%-20.48%-19.34%
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
-5.00%+0.88%-1.34%-23.59%+50.26%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Onsemi stock logo
ON
Onsemi
4.7672 of 5 stars
4.32.00.03.22.91.73.1
Pfizer Inc. stock logo
PFE
Pfizer
4.9727 of 5 stars
3.33.04.24.22.83.33.1
RH stock logo
RH
RH
4.6157 of 5 stars
4.33.00.01.41.84.21.9
Roche Holding AG stock logo
RHHBY
Roche
N/AN/AN/AN/AN/AN/AN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
0.1746 of 5 stars
0.00.01.70.02.80.00.0
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
4.6922 of 5 stars
4.41.00.04.23.22.51.9
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
4.3906 of 5 stars
3.52.00.04.82.44.20.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Onsemi stock logo
ON
Onsemi
2.52
Moderate Buy$66.8558.59% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.59
Moderate Buy$31.9224.70% Upside
RH stock logo
RH
RH
2.63
Moderate Buy$431.6099.24% Upside
Roche Holding AG stock logo
RHHBY
Roche
2.50
Moderate BuyN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
0.00
N/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
2.83
Moderate Buy$170.4173.23% Upside
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
3.00
Buy$22.60120.06% Upside

Current Analyst Ratings Breakdown

Latest SRPT, PFE, WVE, RHHBY, ON, RH, and RHHVF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/7/2025
Onsemi stock logo
ON
Onsemi
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$60.00
3/7/2025
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Perform$105.00
3/5/2025
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00 ➝ $22.00
3/3/2025
Onsemi stock logo
ON
Onsemi
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$57.00 ➝ $57.00
2/27/2025
Onsemi stock logo
ON
Onsemi
Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$49.00 ➝ $49.00
2/27/2025
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$165.00 ➝ $161.00
2/27/2025
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$202.00 ➝ $202.00
2/27/2025
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell$75.00 ➝ $75.00
2/25/2025
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$26.00
(Data available from 3/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Onsemi stock logo
ON
Onsemi
$7.08B2.51$4.19 per share10.06$20.92 per share2.01
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.28$4.01 per share6.38$15.81 per share1.62
RH stock logo
RH
RH
$3.11B1.30$11.36 per share19.07($16.16) per share-13.40
Roche Holding AG stock logo
RHHBY
Roche
$68.73B3.98$3.34 per share12.82$5.81 per share7.38
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/AN/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$1.90B5.02N/AN/A$9.19 per share10.70
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$108.30M14.55N/AN/A$0.40 per share25.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Onsemi stock logo
ON
Onsemi
$1.57B$3.6311.6111.4516.7422.21%20.10%12.36%5/5/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4118.168.450.6412.62%19.47%8.09%4/29/2025 (Estimated)
RH stock logo
RH
RH
$127.56M$3.4862.2515.712.652.25%-35.72%2.09%3/26/2025 (Estimated)
Roche Holding AG stock logo
RHHBY
Roche
$9.40BN/A0.0014.292.18N/AN/AN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
N/A$10.8131.62N/AN/AN/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
-$535.98M$2.2878.708.99N/A7.43%11.00%3.35%5/7/2025 (Estimated)
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
-$57.51M-$0.79N/AN/AN/A-66.50%-280.57%-52.90%5/8/2025 (Estimated)

Latest SRPT, PFE, WVE, RHHBY, ON, RH, and RHHVF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2025N/A
RH stock logo
RH
RH
$1.90N/AN/AN/A$828.21 millionN/A
3/4/2025Q4 2024
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
-$0.17$0.17+$0.34$0.17$25.60 million$83.75 million
2/10/2025Q4 2024
Onsemi stock logo
ON
Onsemi
$0.98$0.95-$0.03$0.88$1.76 billionN/A
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Onsemi stock logo
ON
Onsemi
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.72%+2.50%121.99%16 Years
RH stock logo
RH
RH
N/AN/AN/AN/AN/A
Roche Holding AG stock logo
RHHBY
Roche
$0.841.96%N/AN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
$7.802.28%N/A72.16%N/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
N/AN/AN/AN/AN/A
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Onsemi stock logo
ON
Onsemi
0.38
5.06
3.38
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
RH stock logo
RH
RH
N/A
1.43
0.33
Roche Holding AG stock logo
RHHBY
Roche
0.86
1.26
0.97
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
0.93
3.84
3.03
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
N/A
1.90
1.90

Institutional Ownership

CompanyInstitutional Ownership
Onsemi stock logo
ON
Onsemi
97.70%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
RH stock logo
RH
RH
90.17%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
29.01%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
86.68%
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
89.73%

Insider Ownership

CompanyInsider Ownership
Onsemi stock logo
ON
Onsemi
0.31%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
RH stock logo
RH
RH
28.10%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
N/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7.70%
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
29.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Onsemi stock logo
ON
Onsemi
26,490421.42 million420.12 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable
RH stock logo
RH
RH
6,50018.60 million13.38 millionOptionable
Roche Holding AG stock logo
RHHBY
Roche
103,6056.38 billionN/ANot Optionable
Roche Holding AG stock logo
RHHVF
Roche
103,605N/AN/ANot Optionable
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1,31497.03 million88.17 millionOptionable
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
240153.49 million108.14 millionOptionable

Recent News About These Companies

Research Analysts Set Expectations for WVE FY2025 Earnings
What is HC Wainwright's Forecast for WVE Q1 Earnings?
Q1 EPS Estimates for Wave Life Sciences Lowered by B. Riley

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Onsemi stock logo

Onsemi NASDAQ:ON

$42.15 -0.70 (-1.63%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$42.66 +0.51 (+1.21%)
As of 08:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

onsemi is engaged in disruptive innovations and also a supplier of power and analog semiconductors. The firm offers vehicle electrification and safety, sustainable energy grids, industrial automation, and 5G and cloud infrastructure, with a focus on automotive and industrial end-markets. It operates through the following segments: Power Solutions Group, Advanced Solutions Group, and Intelligent Sensing Group. The Power Solutions Group segment offers discrete, module, and semiconductor products that perform multiple application functions, including power switching, power conversion, signal conditioning, circuit protection, signal amplification, and voltage reference functions. The Advanced Solutions Group segment is involved in the designing and developing of analog, mixed-signal, advanced logic, ASSPs and ASICs, Wi-Fi and power solutions for a broad base of end-users in the automotive, consumer, computing, industrial, communications, medical and aerospace/defense markets. The Intelligent Sensing Group segment is focused on the designing and developing of CMOS and CCD image sensors, as well as proximity sensors, image signal processors, single photon detectors, inclu

Pfizer stock logo

Pfizer NYSE:PFE

$25.60 -0.11 (-0.43%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$25.68 +0.08 (+0.32%)
As of 08:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

RH stock logo

RH NYSE:RH

$216.62 -24.40 (-10.12%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$222.14 +5.52 (+2.55%)
As of 08:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RH, together with its subsidiaries, operates as a retailer in the home furnishings market. The company offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, baby, child, and teen furnishings. It provides its products through rh.com, rhbabyandchild.com, rhteen.com, rhmodern.com, and waterworks.com online channels, as well as operates RH Galleries, RH outlet stores, RH Guesthouse, and Waterworks showrooms in the United States, Canada, the United Kingdom, and Germany. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.

Roche stock logo

Roche OTCMKTS:RHHBY

$42.86 -0.70 (-1.61%)
As of 03/13/2025 04:00 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Roche stock logo

Roche OTCMKTS:RHHVF

$341.79 -5.21 (-1.50%)
As of 03/13/2025 02:26 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Sarepta Therapeutics stock logo

Sarepta Therapeutics NASDAQ:SRPT

$98.37 -1.40 (-1.40%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$99.61 +1.24 (+1.26%)
As of 07:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Wave Life Sciences stock logo

Wave Life Sciences NASDAQ:WVE

$10.27 -0.54 (-5.00%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$10.45 +0.18 (+1.74%)
As of 08:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.